Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.

Marchini, Antonio; Daeffler, Laurent; Pozdeev, Vitaly I; Angelova, Assia; Rommelaere, Jean

Marchini, Antonio; Daeffler, Laurent; Pozdeev, Vitaly I; Angelova, Assia; Rommelaere, Jean.

Afiliación

Marchini A; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Daeffler L; Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research Center, Heidelberg, Germany.
Pozdeev VI; Université de Strasbourg, IPHC, Strasbourg, France.
Angelova A; CNRS, UMR7178, Strasbourg, France.
Rommelaere J; Laboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of Health, Luxembourg, Luxembourg.

Front Immunol ; 10: 1848, 2019.

Article en En | MEDLINE | ID: mdl-31440242

Asunto(s)

Parvovirus H-1/inmunología; Neoplasias/inmunología; Neoplasias/terapia; Viroterapia Oncolítica; Virus Oncolíticos/inmunología; Microambiente Tumoral/inmunología; Humanos

Palabras clave

H-1PV; checkpoint blockade; combination therapy; immunogenic cell death; immunotherapy; oncolytic viruses; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus Oncolíticos / Viroterapia Oncolítica / Parvovirus H-1 / Microambiente Tumoral / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article País de afiliación: Luxemburgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google